Gene Amplification Technologies Market (By Technology: PCR-based Amplification, Multiple Displacement Amplification, Nucleic Acid Sequence Based Amplification, Loop-mediated Isothermal Amplification, Strand Displacement Amplification, Rolling Circle Amplification, Ramification Amplification, and Others); By Product: Instruments, Kits & Reagents and Services; By Sample Type: FFPE, Single Cell, and Others; By Application: Whole Genome Amplification, Exome Sequencing, SNP Genotyping Arrays, Array CGH, Hybridization, and Others; By End-Use: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others) – Global Industry Analysis, Market Size, Opportunities and Forecast 2021-2028

CHAPTER 1. Industry Overview of Gene Amplification Technologies

1.1. Definition and Scope 

1.1.1. Definition of Gene Amplification Technologies

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Gene Amplification Technologies market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Gene Amplification Technologies By Technology

1.2.3. Gene Amplification Technologies By Application

1.2.4. Gene Amplification Technologies By Product

1.2.5. Gene Amplification Technologies By Sample Type

1.2.6. Gene Amplification Technologies By End-User

1.2.7. Gene Amplification Technologies by Regions

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restrain 1

3.2.2. Restrain 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Gene Amplification Technologies Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Gene Amplification Technologies Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2019

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019

4.2. R&D Status and Application Source of Gene Amplification Technologies Major Manufacturers in 2019

CHAPTER 5. Gene Amplification Technologies By Technology

5.1. Introduction

5.2. Gene Amplification Technologies Revenue By Technology

5.2.1. Gene Amplification Technologies Revenue (US$ Bn) and Forecast, By Technology, 2017-2028

5.2.2. PCR-based Amplification

5.2.2.1. PCR-based Amplification Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.3. Nucleic Acid Sequence Based Amplification

5.2.3.1. Nucleic Acid Sequence Based Amplification Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.4. Multiple Displacement Amplification

5.2.4.1. Multiple Displacement Amplification  Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.5. Loop-mediated Isothermal Amplification

5.2.5.1. Loop-mediated Isothermal Amplification Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.6. Strand Displacement Amplification

5.2.6.1. Strand Displacement Amplification Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.7. Rolling Circle Amplification

5.2.7.1. Rolling Circle Amplification Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.8. Ramification Amplification

5.2.8.1. Ramification Amplification Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

5.2.9. Others

5.2.9.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 6. Gene Amplification Technologies Market Revenue By Application

6.1. Introduction

6.2. Gene Amplification Technologies Revenue (US$ Bn) By Application

6.2.1. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

6.2.2. Whole Genome Amplification

6.2.2.1. Whole Genome Amplification Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.3. Exome Sequencing

6.2.3.1. Exome Sequencing Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.4. SNP Genotyping Arrays

6.2.4.1. SNP Genotyping Arrays Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.5. Array CGH

6.2.5.1. Array CGH Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.6. Hybridization

6.2.6.1. Hybridization  Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

6.2.7. Others

6.2.7.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 7. Gene Amplification Technologies Market By Sample Type 

7.1. Introduction

7.2. Gene Amplification Technologies Revenue (US$ Bn) By Product

7.2.1. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

7.2.2. Single Cell

7.2.2.1. Single Cell Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

7.2.3. FFPE

7.2.3.1. FFPE Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

7.2.4. Others

7.2.4.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 8. Gene Amplification Technologies Market By Product 

8.1. Introduction

8.2. Gene Amplification Technologies Revenue (US$ Bn) By Product

8.2.1. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

8.2.2. Instruments

8.2.2.1. Instruments Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

8.2.3. Kits & Reagents

8.2.3.1. Kits & Reagents Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

8.2.4. Others

8.2.4.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 9. Gene Amplification Technologies Market By End-User 

9.1. Introduction

9.2. Gene Amplification Technologies Revenue (US$ Bn) By Product

9.2.1. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

9.2.2. Pharmaceuticals & Biotechnology Companies

9.2.2.1. Pharmaceuticals & Biotechnology Companies Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

9.2.3. Academic & Research Institutes

9.2.3.1. Academic & Research Institutes Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

9.2.4. Others

9.2.4.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028

CHAPTER 10. North America Gene Amplification Technologies Market By Country 

10.1. North America Gene Amplification Technologies Overview

10.2. U.S.

10.2.1. U.S. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

10.2.2. U.S. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

10.2.3. U.S. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

10.2.4. U.S. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

10.2.5. U.S. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

10.3. Canada

10.3.1. Canada Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

10.3.2. Canada Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

10.3.3. Canada Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

10.3.4. Canada Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

10.3.5. Canada Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

10.4. North America PEST Analysis

CHAPTER 11. Europe Gene Amplification Technologies Market By Country

11.1. Europe Gene Amplification Technologies Overview

11.2. U.K.

11.2.1. U.K. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

11.2.2. U.K. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

11.2.3. U.K. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

11.2.4. U.K. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

11.2.5. U.K. Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.3. Germany

11.3.1. Germany Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

11.3.2. Germany Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

11.3.3. Germany Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

11.3.4. Germany Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

11.3.5. Germany Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.4. France 

11.4.1. France Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

11.4.2. France Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

11.4.3. France Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

11.4.4. France Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

11.4.5. France Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.5. Spain

11.5.1. Spain Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

11.5.2. Spain Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

11.5.3. Spain Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

11.5.4. Spain Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

11.5.5. Spain Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.6. Rest of Europe

11.6.1. Rest of Europe Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

11.6.2. Rest of Europe Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

11.6.3. Rest of Europe Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

11.6.4. Rest of Europe Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

11.6.5. Rest of Europe Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

11.7. Europe PEST Analysis

CHAPTER 12. Asia Pacific Gene Amplification Technologies Market By Country

12.1. Asia Pacific Gene Amplification Technologies Overview

12.2. China

12.2.1. China Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

12.2.2. China Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

12.2.3. China Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

12.2.4. China Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

12.2.5. China Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

12.3. Japan

12.3.1. Japan Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

12.3.2. Japan Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

12.3.3. Japan Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

12.3.4. Japan Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

12.3.5. Japan Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

12.4. India

12.4.1. India Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

12.4.2. India Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

12.4.3. India Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

12.4.4. India Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

12.4.5. India Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

12.5. Australia

12.5.1. Australia Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

12.5.2. Australia Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

12.5.3. Australia Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

12.5.4. Australia Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

12.5.5. Australia Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

12.6. South Korea

12.6.1. South Korea Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

12.6.2. South Korea Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

12.6.3. South Korea Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

12.6.4. South Korea Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

12.6.5. South Korea Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

12.7. Rest of Asia-Pacific

12.7.1. Rest of Asia-Pacific Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

12.7.2. Rest of Asia-Pacific Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

12.7.3. Rest of Asia-Pacific Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

12.7.4. Rest of Asia-Pacific Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

12.7.5. Rest of Asia-Pacific Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

12.8. Asia Pacific PEST Analysis

CHAPTER 13. Latin America Gene Amplification Technologies Market By Country

13.1. Latin America Gene Amplification Technologies Overview

13.2. Brazil

13.2.1. Brazil Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

13.2.2. Brazil Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

13.2.3. Brazil Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

13.2.4. Brazil Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

13.2.5. Brazil Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-202

13.3. Mexico

13.3.1. Mexico Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

13.3.2. Mexico Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

13.3.3. Mexico Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

13.3.4. Mexico Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

13.3.5. Mexico Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

13.4. Rest of Latin America

13.4.1. Rest of Latin America Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

13.4.2. Rest of Latin America Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

13.4.3. Rest of Latin America Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

13.4.4. Rest of Latin America Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

13.4.5. Rest of Latin America Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

13.5. Latin America PEST Analysis

CHAPTER 14. Middle East & Africa Gene Amplification Technologies Market By Country 

14.1. Middle East & Africa Gene Amplification Technologies Overview

14.2. GCC

14.2.1. GCC Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

14.2.2. GCC Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

14.2.3. GCC Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

14.2.4. GCC Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

14.2.5. GCC Gene Amplification Technologies Revenue (US$ Bn) and Forecast By GCC, 2017-2028

14.3. South Africa

14.3.1. South Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

14.3.2. South Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

14.3.3. South Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

14.3.4. South Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

14.3.5. South Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By South Africa, 2017-2028

14.4. Rest of Middle East & Africa

14.4.1. Rest of Middle East & Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Technology, 2017-2028

14.4.2. Rest of Middle East & Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Application, 2017-2028

14.4.3. Rest of Middle East & Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Sample Type, 2017-2028

14.4.4. Rest of Middle East & Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By Product, 2017-2028

14.4.5. Rest of Middle East & Africa Gene Amplification Technologies Revenue (US$ Bn) and Forecast By End-User, 2017-2028

14.5. Middle East & Africa PEST Analysis

CHAPTER 15. Player Analysis Of Gene Amplification Technologies

15.1. Gene Amplification Technologies Company Share Analysis

15.2. Competition Matrix

15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

15.2.2. New Product Launches and Product Enhancements

15.2.3. Mergers And Acquisition In Global Gene Amplification Technologies market

15.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 16. COMPANY PROFILE

16.1. Abbott Laboratories 

16.1.1. Company Snapshot

16.1.2. Business Overview

16.1.3. Financial Overview

16.1.3.1. Revenue (US$ Bn), 2020

16.1.3.2. Abbott Laboratories 2020 Gene Amplification Technologies Business Regional Distribution

16.1.4. Product/ Service and Specification

16.1.5. Recent Developments & Business Strategy

16.1.6. Manufacturing Plant Footprint Analysis

16.2. Ambion, Inc.

16.3. Bio-Rad Laboratories

16.4. Agilent Technologies, Inc.

16.5. Danaher Corporation

16.6. Illumina Inc.

16.7. Merck KGaA

16.8. Promega Corporation

16.9. QIAGEN N.V.

16.10. Silicon Biosystems

16.11. Takara Bio, Inc.

16.12. Vazyme Biotech Co. Ltd.